The global Alprazolam Tablets Market is estimated to be valued at US$ 2,815.66 Mn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Alprazolam tablets are prescription medication primarily used for the treatment of anxiety disorders like generalized anxiety...
Alprazolam tablets are commonly prescribed benzodiazepines used for the treatment of anxiety and panic disorders such as generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and post-traumatic stress disorder (PTSD). The tablets work by calming the brain and nerves. Advantages associated with alprazolam tablets include fast-acting properties, improved quality of life,...
Alprazolam tablets, commonly known as Xanax, are prescribed as an effective treatment for generalized anxiety disorder and panic disorder. Xanax works by enhancing the effects of the gamma-aminobutyric acid (GABA) neurotransmitter in the brain. GABA helps produce a calming effect. Xanax tablets are available in various forms and dosages including immediate and extended release. The rising...
The global alprazolam tablets market has been witnessing significant growth in recent years. Alprazolam tablets are benzodiazepine tranquilizers that are commonly prescribed to treat conditions like anxiety disorders, panic disorders, and anxiety caused by depression. The tablets work by enhancing the effects of the gamma-aminobutyric acid (GABA) neurotransmitter in the brain. This helps in...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian